The World Intellectual Property Organization (WIPO), the World Health Organization (WHO) and the International Telecommunication Union (ITU) have jointly released AI-enabled Health Innovation and IP: From idea to impact. Developed under the Global Initiative on AI for Health, the publication is designed for innovators, start-ups, research institutions and partners seeking to move AI-based health technologies from early development to practical deployment. It covers patents, trade secrets, copyright and data protection, alongside licensing, collaboration, regulation, health-data governance and standards.
The publication is most useful because it treats intellectual property, regulation and commercialization as connected decisions rather than separate workstreams. AI health products often depend on algorithms, training data, clinical validation and continuous updates, so a patent-only strategy can leave major gaps around confidentiality, data rights and regulatory disclosure. Teams should build patent filing, trade-secret controls, contracts and data governance into the project from the outset, then revisit that mix as validation, approval and market deployment progress.
